Close button
Enquiry IconContact Us
Logo
  • Choose License Type

Global Immunohistochemistry (IHC) Market, by Product (Antibodies (Primary Antibodies and Secondary Antibodies), Equipment (Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, and Others), Reagents (Histological Stains, Blocking Sera and Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, and Others), and Kits), by Application (Diagnostics (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus, and Others), Drug Testing, and Forensic Applications), by End User (Hospitals, Diagnostic Laboratories, Research Institutes, and Others), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) was valued at US$ 2,020.2 Million in 2021 and is projected to exhibit a CAGR of 7.5% during the forecast period (2021-2028).

The increasing regulatory approvals and launches of novel IHC products are expected to support the global immunohistochemistry (IHC) market growth. For instance, in June 2019, the U.S. Food and Drug Administration (FDA) approved the expanded use of Agilent Technologies’ PD-L1 IHC 22C3 pharmDx assay for the detection of head and neck squamous cell carcinoma (HNSCC). This product is used in patients receiving cancer treatment with Merck and Co., Inc.’s Keytruda (Pembrolizumab). The kit includes reagents used for the immunohistochemical staining, control slides that represents positive and negative PD-L1 protein expression, along with detailed instructions. The kit has been designed especially for use on Autostainer Link 48 instruments.

Global Immunohistochemistry (IHC) Market – Impact of Coronavirus (COVID-19) Pandemic

COVID-19 pandemic has affected various industries globally. The players operating in the global immunohistochemistry (IHC) market are facing major challenges on various fronts due to the COVID-19 pandemic. According to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, the number of COVID-19 cases reported globally, as of November 23, 2021, are approximately 257,469,528 confirmed cases with 5,158,211 deaths.

The COVID-19 pandemic caused major disruptions to clinical trial executions in the U.S., impacting key stakeholders across the industry. Investigative site capabilities experienced disturbances, driven by staff furloughs, social-distancing protocols, financial losses, and concerns over patient safety. Sponsors, contract research organizations, and other organizations that support drug development shifted to remote working environments.

Browse 35 Market Data Tables and 50 Figures spread through 142 Pages and in-depth TOC on “Global Immunohistochemistry (IHC) Market”-  Forecast to 2028,  Global Immunohistochemistry (IHC) Market, by Product (Antibodies (Primary Antibodies and Secondary Antibodies), Equipment (Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, and Others), Reagents (Histological Stains, Blocking Sera and Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, and Others), and Kits), by Application (Diagnostics (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus, and Others), Drug Testing, and Forensic Applications), by End User (Hospitals, Diagnostic Laboratories, Research Institutes, and Others), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) – Forecast to 2028

To know the latest trends and insights prevalent in the Global Immunohistochemistry (IHC) Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/immunohistochemistry-market-4795

The key players operating in the global immunohistochemistry (IHC) market are focusing on product launches to increase their market presence in the global market. For instance, in May 2019, F. Hoffmann-La Roche AG, a Swiss multinational healthcare company, launched VENTANA ROS1 (SP384), its new Rabbit Monoclonal Primary Antibody that is intended for the detection of ROS1-positive cancer cases. It binds to ROS1 protein in formalin-fixed, paraffin-embedded (FFPE) tissue specimens.

Key Takeaways of the Global Immunohistochemistry (IHC) Market:

  • The global immunohistochemistry (IHC) market is expected to exhibit a CAGR of 7.5% during the forecast period, owing to the increasing prevalence of cardiovascular diseases (CVDs). For instance, according to the fact sheet published by World Health Organization (WHO) in June 2021, cardiovascular diseases (CVDs) are the leading cause of death globally. Moreover, according to the same source, around 17.9 million people died from CVDs in the year 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke.
  • Among product, antibodies segment is expected to dominate the market due to their continued use in IHC procedures for disease diagnosis and drug testing. Antibody-related products such as therapeutic monoclonal antibodies and antibody fragments, Fc fusion proteins, and antibody drug conjugates are among the market-leading product class.
  • Among application, diagnostics segment is expected to dominate the market and is expected to experience the highest growth over the forecast period. The growth of this segment is primarily due to factors such as the benefits of IHC over traditionally used specialized enzyme staining techniques, growing predominance of cancer and application of IHC in the diagnosis of cancers, infectious diseases, cardiovascular diseases, and other diseases.
  • Major players operating in the global immunohistochemistry (IHC) market include Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Danaher Corporation, Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Bio SB, Agilent Technologies, Inc., Abcam plc., Becton, Dickinson and Company, Takara Bio, Inc., Eagle Biosciences, Inc., Biocare Medical, LLC, Biogenex Laboratories, Diagnostic Biosystems, Inc., and BioVision Inc.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly subscribe for our latest news & articles.